3D Medicines Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 352.55 million compared to CNY 207.03 million a year ago. Net loss was CNY 178.49 million compared to CNY 308.45 million a year ago.

Basic loss per share from continuing operations was CNY 0.79 compared to CNY 8.41 a year ago.